Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area dna damage dna pk'

Search results for: 'research area dna damage dna pk'

Items 231-240 of 445

Page
per page
  1. Yonkenafil
    BA8213 Yonkenafil
    Summary: Yonkenafil (Tunodafil) is a novel phosphodiesterase 5 inhibitor that is effective in reducing cerebral infarction, neurological deficits, edema, and neuronal damage in the infarcted area.
  2. Triciribine
    A8541 Triciribine
     5 Citation
    Summary: Akt inhibitor,highly selective
      insoluble in H2O; insoluble in EtOH; ≥118.4 mg/mL
  3. Nitracrine
    BA4087 Nitracrine
    Summary: Nitracrine inhibits RNA synthesis, covalently, reversibly binds to DNA, and forms covalent adducts with DNA in vivo.
  4. Neocarzinostatin
    BA1066 Neocarzinostatin
    Summary: Neocarzinostatin is a potent damaging, antitumor antibiotic that recognizes double-stranded DNA expansion and induces DNA double-strand breaks (DSBs).
  5. DACA
    BA4556 DACA
    Summary: DACA inhibits two essential nucleases, DNA topoisomerase I (topoI) and DNA topoisomerase II (topoII), in vitro.
  6. Oxolinic acid
    B6129 Oxolinic acid
    Summary: quinolone antibiotic that inhibits bacterial DNA gyrase
      ≥2.09 mg/mL
  7. 2',3',5'-triacetyl-5-Azacytidine
    C4119 2',3',5'-triacetyl-5-Azacytidine
    Summary: prodrug form of 5-azacytidine, a DNA methyltransferase inhibitor
      ≤30 mg/mL
  8. Flumequine
    B2292 Flumequine
    Summary: DNA topoisomerase II inhibitor，synthetic chemotherapeutic antibiotic
      insoluble in EtOH; insoluble in H2O; ≥9.35 mg/mL
  9. Bleomycin Sulfate
    A8331 Bleomycin Sulfate
     1 Citation
    Summary: Chemotherapy agent, induces DNA strand break
      ≥125 mg/mL
  10. Amrubicin
    BA1273 Amrubicin
    Summary: Amrubicin (SM-5887) is a DNA topoisomerase II inhibitor.

Items 231-240 of 445

Page
per page